Skip to main content
. 2022 Mar 28;9:828478. doi: 10.3389/fcvm.2022.828478

Table 4.

Linear regression analysis of the ΔPVR in the patients.

Univariate analysis Multivariate analysis
B (95% CI) P -value B (95% CI) P -value
Age −0.010 (−0.025–0.004) 0.158
Male 0.061 (−0.211–0.333) 0.660
Paroxysmal AF −0.047 (−0.302–0.207) 0.715
Body mass index 0.023 (−0.020–0.067) 0.294
Diabetes mellitus 0.383 (0.096–0.671) 0.009 0.365 (0.057–0.673) 0.020
Hypertension 0.069 (−0.185–0.323) 0.594
Congestive heart failure −0.162 (−0.533–0.210) 0.394
Stroke 0.014 (−0.341–0.369) 0.937
Vascular disease −0.036 (−0.366–0.293) 0.829
LA diameter −0.017 (−0.038–0.004) 0.122
LVEF 0.008 (−0.007–0.023) 0.287
LA volume/BSA −0.006 (−0.011–0.000) 0.034 −0.005 (−0.011–0.000) 0.057
Pericardial fat volume 0.000 (−0.002–0.003) 0.742
LA pressure, peak −0.016 (−0.030–−0.003) 0.018 −0.015 (−0.029–−0.001) 0.034
LA voltage 0.049 (−0.139–0.237) 0.609
LA wall stress −0.001 (−0.003–0.000) 0.097
Stiff LA physiology 1.065 (0.427–1.702) 0.001 1.402 (0.701–2.103) <0.001
Extra PV LA ablation 0.076 (−0.183–0.335) 0.564
Extra PV trigger −0.060 (−0.488–0.367) 0.781

PVR, pulmonary vascular resistance; AF, atrial fibrillation; LA, left atrium; LVEF, left ventricular ejection fraction; BSA, body surface area; PV, pulmonary vein.